<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="41">
  <stage>Registered</stage>
  <submitdate>19/07/2005</submitdate>
  <approvaldate>22/07/2005</approvaldate>
  <actrnumber>ACTRN12605000031662</actrnumber>
  <trial_identification>
    <studytitle>Clinical trial of dermoscopy and digital monitoring in general practice</studytitle>
    <scientifictitle>Crossover trial of dermoscopy and short-term digital monitoring for the management of skin lesions in general practice</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Suspicious pigmented skin lesions</healthcondition>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Dermatological conditions</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Two instrumental interventions, dermoscopy (Heine Delta 10, Heine Ltd, Germany) and digital monitoring (SolarScan adapted instrument, Polartechnics Ltd, Sydney) will be used to examine pigmented skin lesions deemed suitable for excision by standard naked eye examination. 80 primary care physicians will be trained in the use of the instruments and will recruit on average 5 lesions/clinician over a 6 month period</interventions>
    <comparator />
    <control>Uncontrolled</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The number of skin lesions excised following dermoscopy, digital monitoring and the combined intervention</outcome>
      <timepoint> Following dermoscopy, digital monitoring and the combined intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The change in the confidence of the primary care physician in their diagnosis of the lesion.</outcome>
      <timepoint>Before and after dermoscopy and digital monitoring.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Satisfaction of the patients with their treatment.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with a suspicious pigmented skin lesion that the primary care physician would normally excise or refer to a specialist for diagnosis.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/09/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>400</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Sydney</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Western Australia</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Western Australia</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Assoc Prof Scott Menzies</name>
      <address>Faculty of Medicine
University of Sydney
Sydney Melanoma Diagnostic Centre
Royal Prince Alfred Hospital
Camperdown NSW 2050</address>
      <phone>+61 2 95158537</phone>
      <fax>+61 2 95155278</fax>
      <email>scott.menzies@email.cs.nsw.gov.</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Kiran Shahid</name>
      <address>Department of General Practice 
University of Western Australia
328 Stirling Highway
Claremont WA 6010</address>
      <phone>+61 8 93219332</phone>
      <fax>+61 8 93846238</fax>
      <email>mswc@bigpond.net.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>